A clinical and therapeutic evaluation of haritakyadi kwath on mutrakriccha w.s.r. to E- coli.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035084

Enrollment

Registered

2021-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B962- Escherichia coli [E. coli ] as thecause of diseases classified elsewhere

Interventions

Intervention1: Haritakyadi kwath: 30ml twice a day orally after meal for 60 days Control Intervention1: Nill: Nill

Eligibility

Inclusion criteria

Inclusion criteria: 1. patient willing to give consent for clinical trial. 2. Patient having any clinical signs and symptoms of mutrakriccha(UTI) 3. Patient with positive urine culture.

Exclusion criteria

Exclusion criteria: 1. Patient with upper urinary tract infection. 2. Pregnant women 3. patient with hematuria, renal failure, nephrotic syndrome.

Design outcomes

Primary

Measure	Time frame
Changes in sign and symptoms of mutrakriccha.Timepoint: 60 days	—

Secondary

Measure	Time frame
Changes in mutrakriccha(UTI) grading score.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Nisha yadav

Madan mohan Malviya government ayurveda college Udaipur 313004

Pankajmarolia@gmail.com9413193101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026